Skip to content
Trial Eligibility
Menu

A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With Asthma

NCT05757102

This study is recruiting at 20 US sites in 14 states, according to its ClinicalTrials.gov record last updated .

Summary

The primary purpose of this study is to evaluate the effects of Fluticasone Furoate (FF)/ Umeclidinium (UMEC)/ Vilanterol (VI) on lung function compared with FF/VI after 24 weeks of treatment.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Asthma

Eligibility basics and study details

Study type
Interventional
Phase
Phase 3
Ages
12 to 17 years
Sex
All
Healthy volunteers
Not accepted
Sponsor
GlaxoSmithKline
Last updated on ClinicalTrials.gov
September 30, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Alabama · 2

  • GSK Investigational Site · Birmingham, AL
  • GSK Investigational Site · Mobile, AL

Arizona · 1

  • GSK Investigational Site · Paradise Valley, AZ

California · 3

  • GSK Investigational Site · Bakersfield, CA
  • GSK Investigational Site · Huntington Beach, CA
  • GSK Investigational Site · Mission Viejo, CA

Colorado · 1

  • GSK Investigational Site · Colorado Springs, CO

Florida · 2

  • GSK Investigational Site · Miami, FL
  • GSK Investigational Site · Miami, FL

Illinois · 1

  • GSK Investigational Site · Normal, IL

Kentucky · 1

  • GSK Investigational Site · Owensboro, KY

Montana · 1

  • GSK Investigational Site · Missoula, MT

New York · 1

  • GSK Investigational Site · The Bronx, NY

Ohio · 2

  • GSK Investigational Site · Cincinnati, OH
  • GSK Investigational Site · Cleveland, OH

Oklahoma · 1

  • GSK Investigational Site · Oklahoma City, OK

South Carolina · 1

  • GSK Investigational Site · Charleston, SC

Texas · 2

  • GSK Investigational Site · Dallas, TX
  • GSK Investigational Site · Kerrville, TX

Wisconsin · 1

  • GSK Investigational Site · Milwaukee, WI

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.